Mylan Claims Fall In IP Suit Over Generic Azilect
Law360 (February 25, 2011, 4:56 PM EST) -- A New Jersey federal judge on Tuesday tossed generics maker Mylan Inc.'s inequitable conduct defenses in a patent infringement suit brought by Teva Pharmaceutical Industries Ltd. over efforts to make a...
To view the full article, register now.
Try Law360 FREE for seven days
Already a subscriber? Click here to login
